— The Science

A smarter way to deliver peptides.

The future isn't replacing injections — it's giving people another option. Lynx uses a new generation of precision oral delivery to make advanced peptide compounds more accessible, more convenient, and more effective than ever before.

Section 01 — The Challenge

Peptides are powerful — but fragile.

Peptides are naturally occurring signaling molecules that regulate everything from cellular repair to hormonal balance. Yet unmodified peptides have a half-life of just 2 to 30 minutes in the human body — a consequence of the same defense and filtration systems that protect us from foreign proteins.

Proteolytic Breakdown

Enzymatic degradation rapidly cleaves peptide bonds, destroying active compounds before they can reach target tissues.

Renal Clearance

Small peptide molecules are efficiently filtered and excreted by the kidneys, drastically shortening systemic exposure time.

Digestive Degradation

The harsh acidic environment of the gastrointestinal tract denatures and destroys peptide structures before absorption can occur.

Section 02 — The Traditional Limitation

Why oral delivery has historically failed.

Most orally consumed peptides have less than 2% bioavailability. For every 100mg taken by mouth, fewer than 2mg ever enters systemic circulation. The remaining 98% is lost — neutralized by stomach acid, broken apart by digestive enzymes, or metabolized during first-pass processing in the liver. This inefficiency has historically forced clinicians to rely almost exclusively on injection-based delivery.

2%
Oral Bioavailability

Traditional oral peptide formats rarely exceed 2% systemic absorption.

98%
Lost Before Absorption

The vast majority of orally consumed peptides never reach the bloodstream.

Section 03 — A New Approach

Oral Dissolving Strips.

ODS technology introduces a non-invasive, precision delivery system designed to work with the body's natural absorption pathways — not against them. Ultra-thin, flexible strips dissolve on contact with the mucosal tissue of the mouth. No water. No swallowing. No preparation.

No water required

Place on the tongue and the strip does the rest — instant, seamless dosing.

No swallowing

Bypasses the swallowing mechanism entirely, eliminating a common barrier to compliance.

No needles

No syringes, no clinical setting required. Anyone can use it, anywhere, at any time.

No refrigeration needed

Stabilized strips travel easily and store at room temperature — no cold chain, no hassle.

Precision formulated

Each strip is precisely dosed, ensuring consistent delivery without the variability of liquids or powders.

Section 04 — How It Works

Engineered for efficient absorption.

The science behind oral dissolving strips is grounded in decades of pharmaceutical research into buccal and sublingual drug delivery. By exploiting the highly vascularized mucosal tissue of the mouth, ODS technology enables peptides to enter systemic circulation directly.

  1. 01
    Strip Placement

    The strip is placed on the tongue or inside the cheek, in direct contact with mucosal tissue.

  2. 02
    Rapid Dissolution

    The proprietary matrix dissolves within seconds, releasing the active peptide in a protected micro-environment.

  3. 03
    Mucosal Absorption

    Peptides are absorbed through the buccal or sublingual mucosa, where blood vessels sit remarkably close to the surface.

  4. 04
    Systemic Circulation

    Actives enter the bloodstream directly — bypassing stomach acid and hepatic first-pass metabolism entirely.

Bypasses first-pass metabolism

Absorbed buccally or sublingually, active compounds enter the bloodstream directly — avoiding stomach acid and hepatic metabolism that eliminates most orally consumed peptides.

Protects the active ingredient

The strip matrix encapsulates peptides in a stabilizing environment, shielding them from oxidation, moisture, and enzymatic attack until the moment of absorption.

Rapid dissolution & uptake

Strips dissolve within seconds of mucosal contact, initiating immediate absorption — critical for compounds where timing and peak plasma windows matter.

Stabilized formulation

Carefully selected excipients support peptide structural integrity through shelf life and the brief window between dissolution and absorption.

Section 05 — What This Means

A better experience, without compromise.

ODS technology doesn't alter a peptide's intrinsic half-life — that's determined by its molecular structure. What it changes is the delivery efficiency and usability equation. By dramatically increasing the proportion of active compound that reaches systemic circulation, the effective impact per dose is meaningfully enhanced.

Improved bioavailability

Significantly enhanced absorption versus traditional capsule or liquid formats — every dose counts.

Reduced dosing frequency

Greater delivery efficiency may support reduced reliance on frequent re-dosing to maintain adequate levels.

Discreet convenience

A portable, needle-free alternative that fits any lifestyle — at home, at the gym, at work, or on the go.

Most supplements die in your stomach.
Ours never go there.

While conventional oral supplements fight a losing battle against digestive enzymes, stomach acid, and first-pass liver metabolism, Lynx takes a fundamentally different path. Active peptides are delivered directly through the mucosal lining of the mouth — eliminating the obstacles that have historically made oral peptide supplementation an exercise in diminishing returns.

This isn't a reformulation. It's a reimagination of the entire delivery model. No needles. No preparation. No compromise. Just a strip that dissolves on your tongue and goes to work immediately.